Like MedImmune, GlaxoSmithKline Takes Aim At Cancer In MD Anderson Cancer Center's Moon Shots Program
Published: Apr 09, 2014
GlaxoSmithKline (GSK) is teaming up with the University of Texas MD Anderson Cancer Center in a research alliance that aims to speed up the development of cancer immunotherapies. As part of MD Anderson’s Moon Shots Program, GSK and the cancer center will look for new potential therapeutic approaches, evaluate patient responses in clinical trials, and use insights gained from the collaboration to develop immunotherapy drugs.
Help employers find you! Check out all the jobs and post your resume.